Stock vs Stock Comparison

IQVIA Holdings Inc. vs Agilent Technologies, Inc.

A wins the Tale of the Tape 7–2.

IQV$182.05
A$137.40

🏆 Tale of the Tape

27
IQVA
8.3%Profitability (Net Margin)18.8%
22.6xValuation (P/E)27.3x
8.5%Efficiency (ROIC)11.8%
4/9Health (Piotroski F)5/9
1.8Safety (Altman Z)4.6
5.9%Growth (Rev YoY)6.7%
0.31Risk (Sharpe 1Y)0.32
3.52xBalance Sheet (D/E)0.89x
5.09%FCF Yield3.41%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.666
252-Day Correlation
0.534
126-Day Correlation

Moderately correlated — some diversification benefit from holding both.

Fundamentals

MetricIQVA
Market Cap$30.4B$38.2B
P/E Ratio22.6x27.3x
Forward P/E12.8x20.5x
P/B4.89x5.37x
Dividend Yield0.75%
Beta1.181.22

Quantitative Metrics

MetricIQVA
DCF Fair Value$109.56$50.34
DCF Upside-36.3%-57.1%
Piotroski F4/95/9
Altman Z1.794.57
Beneish M-2.59-2.46
FCF Yield5.09%3.41%
Net Debt/EBITDA3.4x0.7x
ROIC8.5%11.8%
WACC10.3%12.1%
ROIC – WACC-1.8pp-0.3pp
Gross Margin33.3%52.4%
Net Margin8.3%18.8%
Rev Growth YoY5.9%6.7%
Sharpe (1Y)0.310.32
Max Drawdown 3Y
FCF Payout Ratio24%

IQV Price

Loading chart...

A Price

Loading chart...

ETF Exposure

IQV found in:

XLV0.53%
VOE0.48%
VHT0.44%
ONEV0.36%
VO0.27%
RSP0.20%
SCHG0.12%
ONEO0.10%
VTV0.10%
SPYV0.10%
IWD0.09%
VONV0.08%
IVV0.07%
SPLG0.06%
ESGV0.06%
ITOT0.06%
SCHX0.05%
SCHB0.05%
SPY0.04%
ACWI0.04%
SPTM0.04%
VTI0.04%
VONE0.04%
VOO0.04%
URTH0.04%
QUS0.02%

A found in:

MOAT1.31%
VOT0.77%
XLV0.61%
VHT0.53%
VO0.33%
ONEV0.29%
RSP0.18%
VIG0.15%
VTV0.13%
SCHV0.12%
SPYV0.11%
IWD0.11%
VONV0.10%
ONEO0.09%
ESGV0.07%
QUS0.07%
SPLG0.07%
IVV0.07%
ITOT0.06%
SCHX0.06%
SCHB0.05%
SPY0.05%
VTI0.05%
VOO0.05%
VONE0.05%
SPTM0.05%
URTH0.04%
ACWI0.04%
DGRW0.04%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

IQV vs A: Head-to-Head Analysis

IQVIA Holdings Inc. (IQV) and Agilent Technologies, Inc. (A) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, A leads 7–2 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, IQV generates a return on invested capital (ROIC) of 8.5% compared to A's 11.8%. This suggests A is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between IQV and A is 0.666, indicating moderate co-movement, with some diversification value from holding both in a portfolio context.

IQV appears in 26 ETFs tracked by SecuritiesDB, while A appears in 29 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, IQV or A?

Our quantitative analysis compares IQV and A across nine fundamental dimensions. A wins the Tale of the Tape 7–2. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are IQV and A correlated?

The 252-day correlation between IQV and A is 0.666. They show moderate correlation — partially diversifying.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.